Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2004 3
2005 3
2006 1
2008 1
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
Feliu J, Firvida JL, Castro J, Madroñal C, Rodríguez-Jaráiz A, Salgado M, Belda-Iniesta C, Casado E, García-Mata J, González-Barón M; Oncopaz Cooperative Group. Feliu J, et al. Cancer Chemother Pharmacol. 2009 Feb;63(3):403-9. doi: 10.1007/s00280-008-0749-z. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398610 Clinical Trial.
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Feliu J, Castañón C, Salud A, Mel JR, Escudero P, Pelegrín A, López-Gómez L, Ruiz M, González E, Juárez F, Lizón J, Castro J, González-Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Br J Cancer. 2005 Nov 28;93(11):1230-5. doi: 10.1038/sj.bjc.6602860. Br J Cancer. 2005. PMID: 16265344 Free PMC article. Clinical Trial.
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.
Feliu J, Salud A, Escudero P, López-Gómez L, Pericay C, Castañón C, de Tejada MR, Rodríguez-García JM, Martínez MP, Martín MS, Sánchez JJ, Barón MG; Oncopaz Cooperative Group and Associated Hospitals. Feliu J, et al. Br J Cancer. 2004 Apr 19;90(8):1502-7. doi: 10.1038/sj.bjc.6601713. Br J Cancer. 2004. PMID: 15083176 Free PMC article. Clinical Trial.
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J, Martin G, Lizón J, Chacón JI, Dorta J, de Castro J, Rodríguez A, Sánchez Heras B, Torrego JC, Espinosa E, González Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Ann Oncol. 2001 Oct;12(10):1369-74. doi: 10.1023/a:1012552525667. Ann Oncol. 2001. PMID: 11762806 Free article. Clinical Trial.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.
De Castro J, Lorenzo A, Morales S, Belón J, Dorta J, Lizón J, Madroñal C, Gallurt PM, Casado E, Feliu J, Barón MG; Oncopaz Cooperative Group. De Castro J, et al. Cancer Chemother Pharmacol. 2005 Feb;55(2):197-202. doi: 10.1007/s00280-004-0869-z. Epub 2004 Aug 21. Cancer Chemother Pharmacol. 2005. PMID: 15322824 Clinical Trial.
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.
Feliu J, Vicent JM, García-Girón C, Constela M, Fonseca E, Aparicio J, Lomas M, Antón-Aparicio L, Dorta FJ, Gonzalez-Baron M; Oncopaz Cooperative Group and Associated Hospitals. Feliu J, et al. Br J Cancer. 2004 Nov 15;91(10):1758-62. doi: 10.1038/sj.bjc.6602217. Br J Cancer. 2004. PMID: 15505621 Free PMC article. Clinical Trial.